{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:52:35Z","timestamp":1773424355645,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15405"],"award-info":[{"award-number":["21K15405"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00277-024-05669-0","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T09:09:44Z","timestamp":1709024984000},"page":"2041-2050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nomogram for predicting survival of patients with diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"103","author":[{"given":"Keiichiro","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-636X","authenticated-orcid":false,"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"1","key":"5669_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood 107(1):265\u2013276. https:\/\/doi.org\/10.1182\/blood-2005-06-2508","journal-title":"Blood"},{"issue":"20","key":"5669_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"9","key":"5669_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse Large B-Cell Lymphoma. N Engl J Med 384(9):842\u2013858. https:\/\/doi.org\/10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"issue":"6769","key":"5669_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503\u2013511. https:\/\/doi.org\/10.1038\/35000501","journal-title":"Nature"},{"issue":"22","key":"5669_CR5","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM, Lymphoma LM, Profiling P (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359(22):2313\u20132323. https:\/\/doi.org\/10.1056\/NEJMoa0802885","journal-title":"N Engl J Med"},{"issue":"26","key":"5669_CR6","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","volume":"33","author":"DW Scott","year":"2015","unstructured":"Scott DW, Mottok A, Ennishi D, Wright GW, Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother C, Abrisqueta P, Boyle M, Meissner B, Telenius A, Savage KJ, Sehn LH, Slack GW, Steidl C, Staudt LM, Connors JM, Rimsza LM, Gascoyne RD (2015) Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. J Clin Oncol 33(26):2848\u20132856. https:\/\/doi.org\/10.1200\/JCO.2014.60.2383","journal-title":"J Clin Oncol"},{"issue":"15","key":"5669_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.18.02403","volume":"37","author":"A Younes","year":"2019","unstructured":"Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppa S, Rai S, Turgut M, Jurczak W, Cheung MC, Gurion R, Yeh SP, Lopez-Hernandez A, Duhrsen U, Thieblemont C, Chiattone CS, Balasubramanian S, Carey J, Liu G, Shreeve SM, Sun S, Zhuang SH, Vermeulen J, Staudt LM, Wilsoninvestigators P W (2019) Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J Clin Oncol 37(15):1285\u20131295. https:\/\/doi.org\/10.1200\/JCO.18.02403","journal-title":"J Clin Oncol"},{"issue":"21","key":"5669_CR8","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1200\/JCO.18.01994","volume":"37","author":"NL Bartlett","year":"2019","unstructured":"Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schoder H, Zelenetz AD, Leonard JP (2019) Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance\/CALGB 50303. J Clin Oncol 37(21):1790\u20131799. https:\/\/doi.org\/10.1200\/JCO.18.01994","journal-title":"J Clin Oncol"},{"issue":"5","key":"5669_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","volume":"20","author":"A Davies","year":"2019","unstructured":"Davies A, Cummin TE, Barrans S, Maishman T, Mamot C, Novak U, Caddy J, Stanton L, Kazmi-Stokes S, McMillan A, Fields P, Pocock C, Collins GP, Stephens R, Cucco F, Clipson A, Sha C, Tooze R, Care MA, Griffiths G, Du MQ, Westhead DR, Burton C, Johnson PWM (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. Lancet Oncol 20(5):649\u2013662. https:\/\/doi.org\/10.1016\/S1470-2045(18)30935-5","journal-title":"Lancet Oncol"},{"issue":"12","key":"5669_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1200\/JCO.20.01366","volume":"39","author":"GS Nowakowski","year":"2021","unstructured":"Nowakowski GS, Chiappella A, Gascoyne RD, Scott DW, Zhang Q, Jurczak W, Ozcan M, Hong X, Zhu J, Jin J, Belada D, Bergua JM, Piazza F, Mocikova H, Molinari AL, Yoon DH, Cavallo F, Tani M, Yamamoto K, Izutsu K, Kato K, Czuczman M, Hersey S, Kilcoyne A, Russo J, Hudak K, Zhang J, Wade S, Witzig TE, Vitolo U (2021) ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. J Clin Oncol 39(12):1317\u20131328. https:\/\/doi.org\/10.1200\/JCO.20.01366","journal-title":"J Clin Oncol"},{"issue":"26","key":"5669_CR11","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1182\/blood-2011-04-345256","volume":"117","author":"G Salles","year":"2011","unstructured":"Salles G, de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Calaminici M, Sander B, Thorns C, Campo E, Molina T, Lee A, Pfreundschuh M, Horning S, Lister A, Sehn LH, Raemaekers J, Hagenbeek A, Gascoyne RD, Weller E (2011) Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood 117(26):7070\u20137078. https:\/\/doi.org\/10.1182\/blood-2011-04-345256","journal-title":"Blood"},{"key":"5669_CR12","doi-asserted-by":"publisher","unstructured":"Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Moller P, Cogliatti S, Lenz G, Trumper L, Loffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, German High-Grade Lymphoma Study G (2017) Clinical Impact of the Cell-of-Origin Classification and the MYC\/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. J Clin Oncol 35 (22):2515-2526https:\/\/doi.org\/10.1200\/JCO.2016.70.3660","DOI":"10.1200\/JCO.2016.70.3660"},{"issue":"3","key":"5669_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/jclinpath-2017-204548","volume":"71","author":"KC Phang","year":"2018","unstructured":"Phang KC, Akhter A, Tizen NMS, Rahman FA, Zahratul Azma R, Elyamany G, Shabani-Rad MT, Masir N, Mansoor A (2018) Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia. J Clin Pathol 71(3):215\u2013220. https:\/\/doi.org\/10.1136\/jclinpath-2017-204548","journal-title":"J Clin Pathol"},{"issue":"1","key":"5669_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ajh.25666","volume":"95","author":"M Abdulla","year":"2020","unstructured":"Abdulla M, Hollander P, Pandzic T, Mansouri L, Ednersson SB, Andersson PO, Hultdin M, Fors M, Erlanson M, Degerman S, Petersen HM, Asmar F, Gronbaek K, Enblad G, Cavelier L, Rosenquist R, Amini RM (2020) Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma. Am J Hematol 95(1):57\u201367. https:\/\/doi.org\/10.1002\/ajh.25666","journal-title":"Am J Hematol"},{"issue":"10","key":"5669_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/PAI.0000000000000843","volume":"28","author":"I Cho","year":"2020","unstructured":"Cho I, Yoon N, Hyeon J, Sim J, Yoo HY, Kim SJ, Kim WS, Ko YH (2020) Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified. Appl Immunohistochem Mol Morphol 28(10):731\u2013740. https:\/\/doi.org\/10.1097\/PAI.0000000000000843","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"5669_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ajcp\/aqaa185","volume":"155","author":"R Crotty","year":"2021","unstructured":"Crotty R, Hu K, Stevenson K, Pontius MY, Sohani AR, Ryan RJH, Rueckert E, Brauer HA, Hudson B, Berlin AM, Rodenbaugh M, Licon A, Haimes J, Iafrate AJ, Nardi V, Louissaint A (2021) Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay. Am J Clin Pathol 155(5):748\u2013754. https:\/\/doi.org\/10.1093\/ajcp\/aqaa185","journal-title":"Am J Clin Pathol"},{"issue":"14","key":"5669_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors P","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors P (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329(14):987\u2013994. https:\/\/doi.org\/10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"issue":"5","key":"5669_CR18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD, Connors JM (2007) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109(5):1857\u20131861. https:\/\/doi.org\/10.1182\/blood-2006-08-038257","journal-title":"Blood"},{"issue":"6","key":"5669_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN (2014) An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123(6):837\u2013842. https:\/\/doi.org\/10.1182\/blood-2013-09-524108","journal-title":"Blood"},{"issue":"23","key":"5669_CR20","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","volume":"135","author":"AS Ruppert","year":"2020","unstructured":"Ruppert AS, Dixon JG, Salles G, Wall A, Cunningham D, Poeschel V, Haioun C, Tilly H, Ghesquieres H, Ziepert M, Flament J, Flowers C, Shi Q, Schmitz N (2020) International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood 135(23):2041\u20132048. https:\/\/doi.org\/10.1182\/blood.2019002729","journal-title":"Blood"},{"issue":"9","key":"5669_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3760\/cma.j.issn.0253-2727.2018.09.007","volume":"39","author":"JL Song","year":"2018","unstructured":"Song JL, Wei XL, Zhang YK, Hao XX, Huang WM, Wei Q, Wei YQ, Feng R (2018) The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 39(9):739\u2013744. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2018.09.007","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"15","key":"5669_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM (2018) Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med 378(15):1396\u20131407. https:\/\/doi.org\/10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"issue":"5","key":"5669_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A, Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M, Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler M, Pfreundschuh M, Trumper L, Getz G, Shipp MA (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24(5):679\u2013690. https:\/\/doi.org\/10.1038\/s41591-018-0016-8","journal-title":"Nat Med"},{"issue":"7332","key":"5669_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470(7332):115\u2013119. https:\/\/doi.org\/10.1038\/nature09671","journal-title":"Nature"},{"issue":"11","key":"5669_CR25","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1634\/theoncologist.2018-0361","volume":"24","author":"Y Han","year":"2019","unstructured":"Han Y, Yang J, Liu P, He X, Zhang C, Zhou S, Zhou L, Qin Y, Song Y, Sun Y, Shi Y (2019) Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Oncologist 24(11):e1251\u2013e1261. https:\/\/doi.org\/10.1634\/theoncologist.2018-0361","journal-title":"Oncologist"},{"issue":"9","key":"5669_CR26","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1038\/bcj.2013.28","volume":"3","author":"W Kraan","year":"2013","unstructured":"Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST (2013) High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J 3(9):e139. https:\/\/doi.org\/10.1038\/bcj.2013.28","journal-title":"Blood Cancer J"},{"issue":"3","key":"5669_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.humpath.2013.10.023","volume":"45","author":"Y Kim","year":"2014","unstructured":"Kim Y, Ju H, Kim DH, Yoo HY, Kim SJ, Kim WS, Ko YH (2014) CD79B and MYD88 mutations in diffuse large B-cell lymphoma. Hum Pathol 45(3):556\u2013564. https:\/\/doi.org\/10.1016\/j.humpath.2013.10.023","journal-title":"Hum Pathol"},{"issue":"7277","key":"5669_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88\u201392. https:\/\/doi.org\/10.1038\/nature08638","journal-title":"Nature"},{"issue":"1","key":"5669_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"issue":"5","key":"5669_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 96(5):644\u2013647. https:\/\/doi.org\/10.1111\/j.1651-2227.2006.00178.x","journal-title":"Acta Paediatr"},{"issue":"3","key":"5669_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.2007.14.1291","volume":"26","author":"MR Weiser","year":"2008","unstructured":"Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD (2008) Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26(3):380\u2013385. https:\/\/doi.org\/10.1200\/JCO.2007.14.1291","journal-title":"J Clin Oncol"},{"issue":"2","key":"5669_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/cncr.28407","volume":"120","author":"PH Montero","year":"2014","unstructured":"Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, Shaha AR, Boyle JO, Kraus DH, Singh B, Wong RJ, Morris LG, Kattan MW, Patel SG (2014) Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer 120(2):214\u2013221. https:\/\/doi.org\/10.1002\/cncr.28407","journal-title":"Cancer"},{"issue":"2","key":"5669_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1245\/s10434-013-3321-y","volume":"21","author":"S Ali","year":"2014","unstructured":"Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I (2014) Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Ann Surg Oncol 21(2):637\u2013642. https:\/\/doi.org\/10.1245\/s10434-013-3321-y","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"5669_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamaoto.2013.3347","volume":"139","author":"S Ali","year":"2013","unstructured":"Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I (2013) A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg 139(7):698\u2013705. https:\/\/doi.org\/10.1001\/jamaoto.2013.3347","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"28","key":"5669_CR35","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","volume":"23","author":"AJ Stephenson","year":"2005","unstructured":"Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23(28):7005\u20137012. https:\/\/doi.org\/10.1200\/JCO.2005.01.867","journal-title":"J Clin Oncol"},{"issue":"23","key":"5669_CR36","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","volume":"28","author":"U Rudloff","year":"2010","unstructured":"Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, Van Zee KJ (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28(23):3762\u20133769. https:\/\/doi.org\/10.1200\/JCO.2009.26.8847","journal-title":"J Clin Oncol"},{"issue":"2","key":"5669_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.sla.0000133125.85489.07","volume":"240","author":"MF Brennan","year":"2004","unstructured":"Brennan MF, Kattan MW, Klimstra D, Conlon K (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240(2):293\u2013298. https:\/\/doi.org\/10.1097\/01.sla.0000133125.85489.07","journal-title":"Ann Surg"},{"issue":"Supplement 1","key":"5669_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1182\/blood-2018-99-117636","volume":"132","author":"JY Song","year":"2018","unstructured":"Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr M, Ottesen R, Nikowitz J, Bedell V, Murata-Collins J, Chen YY, Li Y, Gomez Luna C, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Nademanee AP, Niland J, Gong Q, Chan WC, Weisenburger DD (2018) New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP. Blood 132(Supplement 1):346\u2013346. https:\/\/doi.org\/10.1182\/blood-2018-99-117636","journal-title":"Blood"},{"issue":"10","key":"5669_CR39","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","volume":"78","author":"X Yu","year":"2018","unstructured":"Yu X, Li W, Deng Q, Li L, Hsi ED, Young KH, Zhang M, Li Y (2018) MYD88 L265P Mutation in Lymphoid Malignancies. Cancer Res 78(10):2457\u20132462. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0215","journal-title":"Cancer Res"},{"issue":"12","key":"5669_CR40","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3324\/haematol.2019.227272","volume":"104","author":"RAL de Groen","year":"2019","unstructured":"de Groen RAL, Schrader AMR, Kersten MJ, Pals ST, Vermaat JSP (2019) MYD88 in the driver\u2019s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications. Haematologica 104(12):2337\u20132348. https:\/\/doi.org\/10.3324\/haematol.2019.227272","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05669-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:05:46Z","timestamp":1715580346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05669-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5669"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05669-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shigeru Kusumoto received grants from Chugai and Kyowa Kirin, and honoraria from Chugai and Kyowa Kirin. Shinsuke Iida received grants from Takeda, Bristol-Myers Squibb, Sanofi, Janssen, Daichi Sankyo, Ono, Abbie, Chugai, Novartis, Otsuka, Amgen, Celgene, Glaxo SmithKlein, Alexion, and Shionogi, and honoraria from Janssen, Sanofi, Takeda, Bristol-Myers Squibb, and Ono. Keiichiro Fujii, Atsushi Inagaki, Ayako Masaki, Mariko Sugiura, Tomotaka Suzuki, Takashi Ishida, and Hiroshi Inagaki have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}